The title compounds 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid(C11H9Cl N2O2, HL)(1) and [Cu(L)2(H2O)](2) were prepared and structurally characterized by elemental analysis, IR and single-crystal X-ray diffraction. Compound 1(C11H9Cl N2O2) crystallizes in the monoclinic system, space group P21/n with a = 7.249(3), b = 20.515(10), c = 7.249(3),β= 96.30°, V = 1071.6(9) ?3, Z = 4, Mr = 236.65, Dc = 1.467 g/cm3, F(000) = 488, GOOF = 1.029, μ= 0.341 mm-1, the final R = 0.0736 and w R = 0.1966 for 1500 observed reflections with I > 2σ(I). Compound 2(C22H18Cl2Cu N4O5) crystallizes in the monoclinic system, space group P21/c with a = 7.2931(6), b = 24.548(2), c = 13.2726(11), β= 99.4040(10)°, V = 2344.2(3) ?3, Z = 4, Mr = 552.84, Dc = 1.566 g/cm3, F(000) = 1124, GOOF = 1.050, μ= 1.201 mm-1, the final R = 0.0376 and w R = 0.1000 for 3626 observed reflections with I > 2σ(I). 1 and 2 are connected through hydrogen bonding interactions to generate 2D and 3D supramolecular structures, respectively. Moreover, the preliminary antibacterial activities of 1 and 2 against the gram positive bacteria(S. aureus, C. albicans and B. subtilis) and gram negative bacteria(E. coli and P. aeruginosa) have been tested by using the microdilution method, and the results indicate that 2 is more active than 1 against the tested bacteria.
